Emory receives $23.7 million to develop pandemic vaccines

DRUID HILLS, Ga. Emory University has received a $23.7 million grant from the National Institute of Allergy and Infectious Diseases, to help the university develop vaccines for such diseases as tuberculosis, malaria, and influenza, according to the Atlanta Journal-Constitution.

Emory, along with several Georgia partners, will design vaccines and conduct clinical trials, an effort expected to enhance Georgia’s status in the world of medical research and potentially provide Georgians with cutting-edge disease prevention programs. Emory’s partners will include the Atlanta-based Centers for Disease Control and Prevention, the Mayo Clinic, the University of Colorado and Kaiser Permanente Georgia, which will help recruit people for clinical trials.

Emory will also receive a $2 million matching grant from the Georgia Research Alliance, a partnership of research universities, industry and the state government.